These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 11042076

  • 1. Stroke.
    Choi D.
    Neurobiol Dis; 2000 Oct; 7(5):552-8. PubMed ID: 11042076
    [No Abstract] [Full Text] [Related]

  • 2. Future of neuroprotective drugs in doubt.
    Birmingham K.
    Nat Med; 2002 Jan; 8(1):5. PubMed ID: 11786882
    [No Abstract] [Full Text] [Related]

  • 3. Oxaloacetate: a novel neuroprotective for acute ischemic stroke.
    Campos F, Sobrino T, Ramos-Cabrer P, Castillo J.
    Int J Biochem Cell Biol; 2012 Feb; 44(2):262-5. PubMed ID: 22085530
    [Abstract] [Full Text] [Related]

  • 4. The phenylpropanoid micronutrient chlorogenic acid improves clinical rating scores in rabbits following multiple infarct ischemic strokes: synergism with tissue plasminogen activator.
    Lapchak PA.
    Exp Neurol; 2007 Jun; 205(2):407-13. PubMed ID: 17439814
    [Abstract] [Full Text] [Related]

  • 5. Finding new drugs to treat stroke.
    Barinaga M.
    Science; 1996 May 03; 272(5262):664-6. PubMed ID: 8614822
    [No Abstract] [Full Text] [Related]

  • 6. Novel therapies for acute ischemic stroke.
    Leker RR, Eichel R, Rafaeli G, Ben-Hur T.
    Isr Med Assoc J; 2006 Nov 03; 8(11):788-92. PubMed ID: 17180832
    [Abstract] [Full Text] [Related]

  • 7. Recent advances in stroke therapy.
    Zivin JA.
    West J Med; 1998 Apr 03; 168(4):261-2. PubMed ID: 9584664
    [No Abstract] [Full Text] [Related]

  • 8. Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little.
    Blacker DJ.
    Med J Aust; 2004 Feb 02; 180(3):142-3; author reply 142-3. PubMed ID: 14748684
    [No Abstract] [Full Text] [Related]

  • 9. [Can the symptoms of stroke be limited?].
    Lindsberg PJ, Kaste M.
    Duodecim; 1997 Feb 02; 113(18):1765-70. PubMed ID: 10892068
    [No Abstract] [Full Text] [Related]

  • 10. Neuroprotective therapies in stroke.
    Zivin JA.
    Drugs; 1997 Feb 02; 54 Suppl 3():83-8; discussion 88-9. PubMed ID: 9360855
    [Abstract] [Full Text] [Related]

  • 11. Stick to the rules.
    Lenzi D, Lenzi GL.
    Cerebrovasc Dis; 2000 Feb 02; 10(1):76-9. PubMed ID: 10629352
    [Abstract] [Full Text] [Related]

  • 12. Is rt-PA useful for stroke after 3 hours?
    Nau JP.
    JAAPA; 2004 Feb 02; 17(2):51-3. PubMed ID: 15307330
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K, Sikinger M, Welzel T, Zoubaa S, Sartor K.
    Rofo; 2004 Jan 02; 176(1):98-105. PubMed ID: 14712413
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotection in acute ischemic stroke: are we there yet?
    Shuaib A.
    Int J Stroke; 2006 May 02; 1(2):100-1. PubMed ID: 18706053
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activator.
    Zhang L, Zhang ZG, Liu X, Hozeska A, Stagliano N, Riordan W, Lu M, Chopp M.
    Thromb Haemost; 2006 Jan 02; 95(1):166-73. PubMed ID: 16543976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.